Evaluating the Long-Term Cost-Effectiveness of Once-Weekly Semaglutide 1 mg Versus Liraglutide 1.8 mg: A Health Economic Analysis in the UK
2023 · Diabetes Therapy · 10 citations
https://doi.org/10.1007/s13300-023-01408-2
Novartis (India)(IN)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
6
Papers
10
Citations
1
h-index
1
i10-index
Abheet Sharma is an academic researcher from Novartis (India). The author has contributed to research in topics: Lipoproteins and Cardiovascular Health & Medication Adherence and Compliance & Rice Cultivation and Yield Improvement. The author has an h-index of 1, co-authored 6 publications.
https://doi.org/10.1007/s13300-023-01408-2
https://doi.org/10.1016/j.jval.2025.09.242
https://doi.org/10.1016/j.jval.2025.09.916
https://doi.org/10.1016/j.jval.2025.09.438
Click to start Chat